SEARCH

SEARCH BY CITATION

References

  • 1
    Jacyna MR, Thomas HC. Pathogenesis and treatment of chronic infection. In: ZuckermanAJ, ThomasHC. eds. Viral hepatitis scientific basis and clinical management. Edinburgh: Churchill Livingstone, 1993: 185205.
  • 2
    Perillo RP. Antiviral therapy of chronic hepatitis B. past, present and future. J Hepatol 1993; 17: S56S63.
  • 3
    Barbera C, Bortolotti F, Crivellaro C, Coscia A, Zancan L, Ca-drobbi P, Nebbia G. et al. Recombinant interferon α2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 1994; 20: 287290.
  • 4
    Alexander GJM, Brahm J, Fagan EA, Smith HM, Daniels HM, Eddleston ALWF, Williams R. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987; 2: 6668.
  • 5
    Perillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL. et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295301.
  • 6
    Lai CL, Lin HJ, Yeoh EK, Lok ASF, Wu PC, Yeung CY. Placebo-controlled trial of recombinant α2-interferon in Chinese HBsAg-carrier children. Lancet 1987; 2: 877890.
  • 7
    Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, Gar-cia-Aguado J, Carreno V. Prospective, randomised controlled trial of interferon-α in children with chronic hepatitis B. Hepatology 1991; 13: 10351039.
  • 8
    Utili R, Sagnelli E, Galanti B, Aprea L, Cesaro G, Digilio L, Filippini P. et al. Prolonged treatment of children with chronic hepatitis B with recombinant α2a-Interferon: a controlled, randomized study. Am J Gastroenterol 1991; 86: 327330.
  • 9
    Bruguera M, Amat L, Garcia O, Lambruschini N, Carnicer J, Bergada A, Orte E. et al. Treatment of chronic hepatitis B in children with recombinant alfa interferon. J Clin Gastroenterol 1993; 17: 296299.
  • 10
    Sokal EM, Wirth S, Goyens P, Depreterre A, Cornu C. Interferon alfa-2b therapy in children with chronic hepatitis B. Gut 1993; 34: S87S90.
  • 11
    Krogsgaard K. Does corticosteroid pre-treatment enhance the effect of alfa interferon treatment in chronic hepatitis B? J Hepatol 1994; 20: 159162.
  • 12
    Reichen J, Bianchi L, Frei PC, Malé P, Lavanchy D, Schmid M. and The Swiss Association for the Study of the Liver. Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. J Hepatol 1994; 20: 168174.
  • 13
    Liaw Y-F, Lin S-M, Chen T-J, Chien R-N, Sheen I-S, Chu C-M. Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. J Hepatol 1994; 20: 174180.
  • 14
    Perillo RP, Regenstein FG, Peters MG, De-Schryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized controlled trial. Ann Intern Med 1988; 109: 95100.
  • 15
    Utili R, Sagnelli E, Gaeta GB, Galanti B, Nardiello S, Felaco F, Pasquale G. et al. Treatment of chronic hepatitis B in children with prednisolone followed by alfa-interferon: a controlled randomized study. J Hepatol 1994; 20: 163167.
  • 16
    Lok ASF, Wu PC, Lai CL, Lau JYN, Leung EKY, Wong LSK, Ma OCK. et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102: 20912097.
  • 17
    Fevery J, Elewaut A, Michielsen P, Nevens F, Van Eyken P, Adler M, Desmet V. Efficacy of interferon alfa-2b with or without prednisolone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. J Hepatol 1990; 11: 81088112.
  • 18
    Lai CL, Lin HJ, Lau JYN, Lok ASF, Wu PC, Chung HT, Wong LSK. et al. Effect of recombinant α-2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 1991; 286: 155163.
  • 19
    Fagan EA, Guarner PA, Perera SDK, Trowbridge R, Rolando N, Davison F, Williams R. Quantitation of hepatitis B virus DNA (HBV-DNA) in serum using the spot hybridization technique and scintillation counting. J Virol Methods 1985; 12: 251262.
  • 20
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 15131520.
  • 21
    Chang MH, Sung JL, Lee CY, Chen CJ, Chen JS, Hsu HY, Lee PI. et al. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 1989; 115: 391396.
  • 22
    Chu CM, Karayiannis P, Fowler MJ, Monjardino J, Liaw YF, Thomas HC. Natural history of chronic hepatitis B virus infection in Taiwan: studies of chronic hepatitis B virus DNA in serum. Hepatology 1985; 5: 431434.
  • 23
    Brook MG, Karayiannis P, Thomas HC. Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors. Hepatology 1989; 10: 761763.
  • 24
    Hofley PM, Chuang E, Mailer E. Alpha-interferon treatment of chronic hepatitis B in children [Abstract]. Hepatology 1994; 20: 301A.
  • 25
    Verucchi G, Attard L, Mori F, Diotallevi S, Miniero R, Sprovieri G, Chiodo F. Interferon alpha is efficient in the treatment of children with chronic hepatitis B [Abstract]. Hepatology 1994; 20: 301A.
  • 26
    Sira JK, Sleight E, Boxall E, Ballard A, Yoong AK, Kelly DA. Treatment of chronic hepatitis B carrier children in the UK [Abstract]. Hepatology 1994; 20: 301A.
  • 27
    Koga Y, Kumashiro R, Yasumoto K, Shakado S, Ono N, Noguchi H, Nagata K. et al. Two fatal cases of hepatitis-B virus carriers after corticosteroid-therapy for bronchial-asthma. Int Med 1992; 31: 208213.